The stock market is collapsing. These 5 actions are not.

0

Text size

Covid-19 vaccine

Scott Olson / Getty Images

Fears of contagion in the indebted Chinese real estate market sent U.S. markets tumbling on Monday as investors pulled back from some of the riskier stocks.

But while some stocks have suffered their worst blow in weeks, a few companies have ignored the general malaise and have emerged as beacons of hope.

The pharmaceutical sector has delivered the biggest results. The Food and Drug Administration’s final decision on Covid-19 booster injections is expected later this week and as most manufacturers of antiviral treatments received an injection in the arm on Wall Street on Monday


Atea Pharma

(ticker: AVIR) stood out with a 13% jump.

He is pioneering the next generation of Covid-19 antivirals and is looking for an oral candidate in the coming months.

Pharmaceutical giant brother


AstraZeneca

(AZN) has had more tangible good news following “groundbreaking” test results for a new breast cancer drug. Shares of the UK-listed drug group, which also operates in the US, said its drug Enhertu reduced the risk of death or disease progression by 72%, according to interim analysis of one trial phase 3 versus trastuzumab emtansine (T-DM1) a treatment that already exists.

American biotechnology


Seagen

(SGEN) rose 3.3% as the market digested interim data from its metastatic cervical cancer study presented on Sunday at the 2021 virtual congress of the European Society for Medical Oncology (ESMO) . American-Swiss biotech


Incyte

also outperformed the market, rising 2.48% in a dismal session for many.

Actions in


Brooks Automation

(BRKS) rose 10.37% after the company sold its chipmaking business Semiconductor Solutions to private equity firm Thomas H. Lee Partners LP for $ 3 billion while retaining its life sciences arm. life.

Write to editors@barrons.com

Leave A Reply

Your email address will not be published.